Found: 5
Select item for more details and to access through your institution.
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1121973
- By:
- Publication type:
- Article
Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness.
- Published in:
- Rheumatology, 2015, v. 54, n. 11, p. 1954, doi. 10.1093/rheumatology/kev228
- By:
- Publication type:
- Article
Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01408-6
- By:
- Publication type:
- Article
Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1368290
- By:
- Publication type:
- Article
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5390, doi. 10.3390/cancers13215390
- By:
- Publication type:
- Article